Top

BMC Anesthesiology

Published in:

Open Access 01-12-2013 | Research article

Perioperative blood transfusions and survival in patients with non-small cell lung cancer: a retrospective study

Authors: Juan P Cata, Varun Chukka, Hao Wang, Lei Feng, Vijaya Gottumukkala, Fernando Martinez, Ara A Vaporciyan

Published in: BMC Anesthesiology | Issue 1/2013

Abstract

Background

Perioperative blood transfusions have been associated with poor clinical outcomes in the context of oncological surgery. Current literature is inconclusive whether blood transfusions are linked to shorter recurrence free and overall survival after lung cancer surgery. We hypothesize that blood transfusions in patients undergoing surgery for non-small cell lung cancer are associated with poor oncological survival.

Methods

After IRB approval, perioperative data from 636 patients who underwent lung cancer surgery was collected. Patients were evaluated for time to tumor recurrence and overall survival.

Results

60 patients were transfused and 576 subjects were not. Patients who received transfusion were more likely to have more advanced disease (p = 0.018), and preoperative low hemoglobin concentrations (p < 0.0001) compared to non-transfused patients. In the multivariable Cox regression analysis, blood transfusion was associated with a significant reduction in recurrence free survival (p = 0.025), HR: 1.55 (95% CI: 1.06-2.27) and overall survival (p = 0.0002) HR: 2.04 (95% CI: 1.41-2.97). However, analysis after propensity score matching between the two groups revealed that the effect of blood transfusion was significant for reduction in overall survival (p = 0.0356), HR: 1.838 (95% CI: 1.04-3.22) but not for recurrence free survival (p = 0.1460), HR: 1.493 (95% CI: 0.87-2.56).

Conclusions

Perioperative administration of red blood cells appears be associated with a decreased overall survival but not recurrence free survival after lung cancer surgery. Our study has the limitations of a retrospective review. Hence, our results should be confirmed by a prospective randomized control trial.

Available only for authorised users

Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA: Cancer J Clin. 2012, 62 (1): 10-29. 10.3322/caac.20138.

Nosotti M, Rebulla P, Riccardi D, Baisi A, Bellaviti N, Rosso L, Santambrogio L: Correlation between perioperative blood transfusion and prognosis of patients subjected to surgery for stage I lung cancer. Chest. 2003, 124 (1): 102-107. 10.1378/chest.124.1.102.CrossRefPubMed

Gwin JL, Keller SM: Blood transfusion practices after resection of intrathoracic neoplasms. J Surg Oncol. 1993, 54 (1): 34-37. 10.1002/jso.2930540110.CrossRefPubMed

Churchhouse AM, Mathews TJ, McBride OM, Dunning J: Does blood transfusion increase the chance of recurrence in patients undergoing surgery for lung cancer?. Interac Cardiovasc Thorac Surg. 2012, 14 (1): 85-90. 10.1093/icvts/ivr025.CrossRef

Funaki S, Sawabata N, Nakagiri T, Shintani Y, Inoue M, Kadota Y, Minami M, Okumura M: Novel approach for detection of isolated tumor cells in pulmonary vein using negative selection method: morphological classification and clinical implications. Eur J Cardiothorac Surg. 2011, 40 (2): 322-327.PubMed

Sawabata N, Okumura M, Utsumi T, Inoue M, Shiono H, Minami M, Nishida T, Sawa Y: Circulating tumor cells in peripheral blood caused by surgical manipulation of non-small-cell lung cancer: pilot study using an immunocytology method. Gen Thorac Cardiovasc Surg. 2007, 55 (5): 189-192. 10.1007/s11748-007-0101-2.CrossRefPubMed

Brunsvig PF, Flatmark K, Aamdal S, Hoifodt H, Le H, Jakobsen E, Sandstad B, Fodstad O: Bone marrow micrometastases in advanced stage non-small cell lung carcinoma patients. Lung Cancer. 2008, 61 (2): 170-176. 10.1016/j.lungcan.2007.12.018.CrossRefPubMed

Sawabata N, Ohta M, Matsumura A, Nakagawa K, Hirano H, Maeda H, Matsuda H: Optimal distance of malignant negative margin in excision of nonsmall cell lung cancer: a multicenter prospective study. Ann Thorac Surg. 2004, 77 (2): 415-420. 10.1016/S0003-4975(03)01511-X.CrossRefPubMed

Felip E, Rosell R, Maestre JA, Rodriguez-Paniagua JM, Moran T, Astudillo J, Alonso G, Borro JM, Gonzalez-Larriba JL, Torres A, et al: Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer. J Clin Oncol. 2010, 28 (19): 3138-3145. 10.1200/JCO.2009.27.6204.CrossRefPubMed

10.

Cata JP, Wang H, Gottumukkala V, Reuben J, Sessler DI: Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. British J Anaesth. 2013, 110 (5): 690-701. 10.1093/bja/aet068.CrossRef

11.

Cata JP, Bauer M, Sokari T, Ramirez MF, Mason D, Plautz G, Kurz A: Effects of surgery, general anesthesia, and perioperative epidural analgesia on the immune function of patients with non-small cell lung cancer. J Clinical Anesth. 2013, 25 (4): 255-262. 10.1016/j.jclinane.2012.12.007.CrossRef

12.

Amato A, Pescatori M: Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev. 2006, 1: CD005033

13.

Ng T, Ryder BA, Chern H, Sellke FW, Machan JT, Harrington DT, Cioffi WG: Leukocyte-depleted blood transfusion is associated with decreased survival in resected early-stage lung cancer. J Thorac Cardiovasc Surg. 2012, 143 (4): 815-819. 10.1016/j.jtcvs.2011.12.031.CrossRefPubMed

14.

Moores DW, Piantadosi S, McKneally MF: Effect of perioperative blood transfusion on outcome in patients with surgically resected lung cancer. Annals Thorac Surg. 1989, 47 (3): 346-351. 10.1016/0003-4975(89)90371-8.CrossRef

15.

Piantadosi S, Moores DW, McKneally MF: The adverse effect of perioperative blood transfusion in lung cancer. Chest. 1994, 106 (6 Suppl): 382S-384S.CrossRefPubMed

16.

Keller SM, Groshen S, Kaiser LR: Blood transfusion and lung cancer recurrence. Ann Thorac Surg. 1989, 48 (5): 746-747.CrossRefPubMed

17.

Thomas P, Michelet P, Barlesi F, Thirion X, Doddoli C, Giudicelli R, Fuentes P: Impact of blood transfusions on outcome after pneumonectomy for thoracic malignancies. European Respir J: Off J European Soc Clinical Respir Physiol. 2007, 29 (3): 565-570.CrossRef

18.

Tartter PI, Burrows L, Kirschner P: Perioperative blood transfusion adversely affects prognosis after resection of stage I (subset N0) non-oat cell lung cancer. J Thorac Cardiovasc Surg. 1984, 88 (5 Pt 1): 659-662.PubMed

19.

Little A, Wu H, Ferguson M, Ho C, Bowers V, Segalin A, Staszek V: Perioperative blood transfusion adversely affects prognosis of patients with stage I non-small-cell lung cancer. Am J Surg. 1990, 160 (6): 630-10.1016/S0002-9610(05)80762-7.CrossRefPubMed

20.

Hyman N, Foster R, DeMeules J, Costanza M: Blood transfusions and survival after lung cancer resection. Am J Surg. 1985, 149 (4): 502-507. 10.1016/S0002-9610(85)80047-7.CrossRefPubMed

21.

Pena CM, Rice TW, Ahmad M, Medendorp SV: Significance of perioperative blood transfusions in patients undergoing resection of stage I and II non-small-cell lung cancers. Chest. 1992, 102 (1): 84-88. 10.1378/chest.102.1.84.CrossRefPubMed

22.

Berardi R, Brunelli A, Tamburrano T, Verdecchia L, Onofri A, Zuccatosta L, Gasparini S, Santinelli A, Scartozzi M, Valeri G, et al: Perioperative anemia and blood transfusions as prognostic factors in patients undergoing resection for non-small cell lung cancers. Lung Cancer. 2005, 49 (3): 371-376. 10.1016/j.lungcan.2005.04.011.CrossRefPubMed

23.

Panagopoulos ND, Karakantza M, Koletsis E, Apostolakis E, Sakellaropoulos GC, Filos KS, Eleni T, Dougenis D: Influence of blood transfusions and preoperative anemia on long-term survival in patients operated for non-small cell lung cancer. Lung Cancer. 2008, 62 (2): 273-280. 10.1016/j.lungcan.2008.02.025.CrossRefPubMed

24.

Rzyman W, Dziadziuszko R, Skokowski J, Wilimski R, Raiter A, Szymanowska A, Jassem J: The influence of blood transfusion on survival in operated non-small cell lung cancer patients. J Thorac Cardiovasc Surg. 2003, 126 (3): 755-760. 10.1016/S0022-5223(03)00217-4.CrossRefPubMed

25.

Little AG, Wu HS, Ferguson MK, Ho CH, Bowers VD, Segalin A, Staszek VM: Perioperative blood transfusion adversely affects prognosis of patients with stage I non-small-cell lung cancer. Am J Surg. 1990, 160 (6): 630-632. 10.1016/S0002-9610(05)80762-7. discussion 633CrossRefPubMed

26.

Ginsberg RJ, Rubinstein LV: Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung cancer study group. Ann Thorac Surg. 1995, 60 (3): 615-622. 10.1016/0003-4975(95)00537-U. discussion 622–613CrossRefPubMed

27.

Zanutto EL: A comparison of propensity score and linear regression analysis of complex survery data. J Data Sci. 2006, 4: 67-91.

28.

Kishida Y, Hirose T, Shirai T, Sugiyama T, Kusumoto S, Yamaoka T, Okuda K, Adachi M, Nakamura A: Myelosuppression induced by concurrent chemoradiotherapy as a prognostic factor for patients with locally advanced non-small cell lung cancer. Oncol Lett. 2011, 2 (5): 949-955.PubMedPubMedCentral

29.

Semenza GL: HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med. 2002, 8 (4 Suppl): S62-S67.CrossRefPubMed

30.

Keller SM, Groshen S, Martini N, Kaiser LR: Blood transfusion and lung cancer recurrence. Cancer. 1988, 62 (3): 606-610. 10.1002/1097-0142(19880801)62:3<606::AID-CNCR2820620327>3.0.CO;2-Q.CrossRefPubMed

31.

Tabutin M, Couraud S, Guibert B, Mulsant P, Souquet PJ, Tronc F: Completion pneumonectomy in patients with cancer: postoperative survival and mortality factors. J Thorac Oncol: Off Publ Int Assoc Study Lung Cancer. 2012, 7 (10): 1556-1562.CrossRef

The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2253/13/42/prepub

Title: Perioperative blood transfusions and survival in patients with non-small cell lung cancer: a retrospective study
Authors: Juan P Cata
Varun Chukka
Hao Wang
Lei Feng
Vijaya Gottumukkala
Fernando Martinez
Ara A Vaporciyan
Publication date: 01-12-2013
Publisher: BioMed Central
Published in: BMC Anesthesiology / Issue 1/2013
Electronic ISSN: 1471-2253
DOI: https://doi.org/10.1186/1471-2253-13-42

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Perioperative blood transfusions and survival in patients with non-small cell lung cancer: a retrospective study

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2013

Adjunctive aerosolized colistin for multi-drug resistant gram-negative pneumonia in the critically ill: a retrospective study

The efficacy of intravenous paracetamol versus dipyrone for postoperative analgesia after day-case lower abdominal surgery in children with spinal anesthesia: a prospective randomized double-blind placebo-controlled study

Breastfeeding and pain relief in full-term neonates during immunization injections: a clinical randomized trial

Procalcitonin as a marker of sepsis and outcome in patients with neurotrauma: an observation study

Burnout in intensive care units - a consideration of the possible prevalence and frequency of new risk factors: a descriptive correlational multicentre study

A prospective study of physician pre-hospital anaesthesia in trauma patients: oesophageal intubation, gross airway contamination and the ‘quick look’ airway assessment